{
    "2019-09-23": [
        [
            {
                "time": "2018-05-15",
                "original_text": "Investors May Want to Follow the Progress of These Biotechs",
                "features": {
                    "keywords": [
                        "investors",
                        "biotechs",
                        "progress"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-20",
                "original_text": "6 Guru Stocks Beating the Market",
                "features": {
                    "keywords": [
                        "guru stocks",
                        "beating",
                        "market"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "Novo Nordisk's Semaglutide in Tablet Form Gets FDA Approval",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Semaglutide",
                        "FDA",
                        "approval"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-10",
                "original_text": "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG",
                "features": {
                    "keywords": [
                        "shareholder alert",
                        "securities fraud",
                        "investigation",
                        "Novartis AG"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}